Project Grant R21EY036169
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$230K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Miami, FL 33136, USA
Similar Awards
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $1,330,026 to The Trustees of the University of Pennsylvania to develop two new mouse models of geographic atrophy, the advanced form of dry age-related macular degeneration (AMD). The research aims to test whether an oral antioxidant called deuterated docosahexaenoic acid (D-DHA) can protect the retinal pigment epithelium (RPE) and prevent or treat AMD progression. The project will...
This Project Grant award, provided by the U.S. National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), will fund research to investigate the role of extracellular matrix stiffness and genetic risk factors in the development of epithelial-to-mesenchymal transition (EMT) in age-related macular degeneration (AMD). The $1,173,062 award, effective September 1, 2024 through March 31, 2029, will support in vitro and ex vivo models to determine how matrix biomechanics impact the...
This $3,120,397 Project Grant award from the National Eye Institute (CFDA Program 93.867 - Vision Research) supports research at the Medical University of South Carolina to develop and characterize a 3D tissue chip model of the retinal pigment epithelium (RPE) and choroid. The goal is to study the influence of genetic risk factors and environmental stressors on complement pathway activation and early-stage age-related macular degeneration (AMD) pathology in this model system. The project...
The National Eye Institute (NEI) awarded a $291,375 Project Grant (CFDA 93.867 - Vision Research) to the University of Connecticut Health Center to develop a novel mouse model for studying age-related choroidal neovascularization (ARCNV), a key hallmark of wet age-related macular degeneration (AMD). The award, spanning from August 1, 2024 to July 31, 2026, aims to systematically characterize the ARCNV model, which mimics the genetic, environmental, and age-related factors associated with wet...
This federal Project Grant award of $247,700.00 from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports the establishment of a chimeric mouse model to study human retinal microglia in vivo. The key objectives are to: Characterize the engraftment and impact of xenotransplanted human microglia in the mouse retina and optic nerve. Use single-cell RNA sequencing to define the transcriptome of the human xenotransplanted microglia and analyze their responses to...
This federal Project Grant award of $620,149 from the National Eye Institute (CFDA 93.867 - Vision Research) supports a research program at the University of Iowa to investigate the use of genome editing techniques, such as base editing and prime editing, to modify genetic risk factors for age-related macular degeneration (AMD). The key objectives are to edit the ARMS2/HTRA1 and CFH gene variants associated with AMD risk in human cell models, including induced pluripotent stem cell-derived...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $253,500.00 to the Icahn School of Medicine at Mount Sinai to reconstruct a human blood-retina barrier and perfused vascular system. The goal is to investigate the role of apolipoprotein E (APOE) variants in age-related macular degeneration (AMD). The project aims to optimize an in vitro human outer blood-retina barrier model to study AMD phenotypes, generate isogenic...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $673,747 to New York University School of Medicine to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system capable of high-resolution (0.5 micrometer) imaging of the retina. The goal is to use this advanced OCT technology to quantify and localize retinal macular pigments and retinal pigment epithelium melanosomes, which are key biomarkers...
This $3,915,141 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will support research at Emory University to investigate the relationship between air pollution exposure, specifically fine particulate matter (PM2.5), and Alzheimer's disease and related dementias (AD/ADRD). The key objectives are to determine 1) which specific PM2.5 components are most neurotoxic, 2) the role of other common air pollutants like carbon monoxide and ozone, and 3) the...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports research at the University of California, Los Angeles (UCLA) focused on understanding the mechanisms by which the retinal pigment epithelium (RPE) ingests and degrades the outer segment tips of photoreceptor cells. The $475,442 award, effective January 1, 2025 through December 31, 2028, will fund experiments using live-cell imaging and in vivo analyses to investigate the molecular processes associated...